Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Exclusion Criteria

• •Any concomitant ocular or neurologic condition in the study eye that could cause macular edema or affect vision (except cataract)
• •History of ocular surgery within 60 days of Baseline in the study eye
• •History of Pan-Retinal Photocoagulation (PRP) or sectorial photocoagulation in the study eye in the 3 months prior to Baseline
• •Significant media opacities in the study eye limiting Optical Coherence Tomography (OCT) quality
• •Uncontrolled Ocular Hypertension (OHT) or advanced glaucoma in the study eye
• •Active ocular inflammation in either eye
• •Study eyes that are aphakic with Posterior Capsule Rent (PCR), Anterior Chamber Intraocular Lens (ACIOL), iris or scleral-fixed Intraocular Lens (IOL) or history of complicated cataract surgery with PCR
• •Prior use of intravitreal corticosteroids in the study eye
• •Patients with contraindications to DEX-I